FDA ‘Aghast’ at Lack of cGMP, AER Compliance by Supplement Manufacturers

FDA ‘Aghast’ at Lack of cGMP, AER Compliance by Supplement Manufacturers - RAPS - News - Article View:

"The US Food and Drug Administration’s (FDA) top dietary supplement regulator said at an industry conference meeting he is “aghast at the degree of non-compliance” when it comes to current good manufacturing practices (cGMPs) and adverse event reporting (AER) in the industry, reports Nutra Ingredients USA.

Speaking 25 April to a meeting convened by the Natural Products Association, Daniel Fabricant, director of FDA’s Dvision of Dietary Supplement Programs, said the industry has been exhibiting a level of non-compliance he says is troubling."

'via Blog this'

Return Home: The Health, Drug, Prescription, and GMP Supersite Blog

SkillsPlus Intl Inc. - GMP and QSR Compliance Training Experts
SkillsPlus Intl Info Blog
The Health, Drug, Prescription, and GMP Supersite Gift Store
GMP Posters by SkillsPlus Intl Inc.

The Health, Drug, Prescription, and GMP Supersite